These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 2785325)
21. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis. Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722 [TBL] [Abstract][Full Text] [Related]
22. RenaGel efficacy in severe secondary hyperparathyroidism. Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746 [TBL] [Abstract][Full Text] [Related]
23. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism. Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002 [TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of osteocalcin in chronic hemodialysis patients]. Nishio S; Hayashi S; Yoshihara H; Kobayagawa H Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881 [TBL] [Abstract][Full Text] [Related]
25. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism. Smith GR; Collinson PO; Kiely PD J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026 [TBL] [Abstract][Full Text] [Related]
26. Influence of sex and age on biochemical bone metabolism parameters. Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999 [TBL] [Abstract][Full Text] [Related]
27. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
28. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism. Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420 [TBL] [Abstract][Full Text] [Related]
30. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. Charles P; Poser JW; Mosekilde L; Jensen FT J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367 [TBL] [Abstract][Full Text] [Related]
31. Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. Torer N; Torun D; Torer N; Micozkadioglu H; Noyan T; Ozdemir FN; Haberal M Transplant Proc; 2009 Nov; 41(9):3642-6. PubMed ID: 19917359 [TBL] [Abstract][Full Text] [Related]
32. Hyperparathyroid bone disease in diabetic renal failure. Cundy TF; Humphreys S; Watkins PJ; Parsons V Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193 [TBL] [Abstract][Full Text] [Related]
33. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Malluche HH; Faugere MC; Fanti P; Price PA Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905 [TBL] [Abstract][Full Text] [Related]
34. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital. Suwan N J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575 [TBL] [Abstract][Full Text] [Related]
35. Serum osteocalcin and bone mineral metabolism following successful renal transplantation. Boiskin I; Epstein S; Ismail F; Thomas SB; Raja R Clin Nephrol; 1989 Jun; 31(6):316-22. PubMed ID: 2665993 [TBL] [Abstract][Full Text] [Related]
36. Conjunctival and corneal calcification and bone metabolism in hemodialysis patients. Tokuyama T; Ikeda T; Sato K; Mimura O; Morita A; Tabata T Am J Kidney Dis; 2002 Feb; 39(2):291-6. PubMed ID: 11840369 [TBL] [Abstract][Full Text] [Related]
37. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein. Riggs BL; Tsai KS; Mann KG J Bone Miner Res; 1986 Dec; 1(6):539-42. PubMed ID: 3509744 [TBL] [Abstract][Full Text] [Related]
38. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients. Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265 [TBL] [Abstract][Full Text] [Related]
39. Anemia and secondary hyperparathyroidism in chronically hemodialyzed patients. Rathaus M; Bernheim J Isr J Med Sci; 1979 May; 15(5):415-7. PubMed ID: 447508 [TBL] [Abstract][Full Text] [Related]
40. Serum osteocalcin (BGP) in tumor-associated hypercalcemia. Body JJ; Cleeren A; Pot M; Borkowski A J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]